Age (years) | ||
 Median | 60.4 | |
 Range | 19–92 | |
Gender | N | % |
 Male | 15 | 58 |
 Female | 11 | 42 |
Cancer type | N | % |
 Lung cancer | 1 | 4 |
 Breast cancer | 2 | 8 |
 Prostate cancer | 3 | 12 |
 AML | 2 | 8 |
 Pancreatic cancer | 2 | 8 |
 Colorectal cancer | 2 | 8 |
 Head and Neck cancer | 4 | 15 |
 Adrenal cancer | 1 | 4 |
 Liver cancer | 1 | 4 |
 Astrocytoma | 1 | 4 |
 Bronchial carcinoid | 1 | 4 |
 Ovarian cancer | 1 | 4 |
 Uterine cancer | 1 | 4 |
 Sarcomatoid | 1 | 4 |
 Squamous cell carcinoma neck | 1 | 4 |
 Esophageal cancer | 1 | 4 |
 Thyroid cancer | 1 | 4 |
Route of administration | N | % |
 Intravenous (IV) | 6 | 23 |
 Intravenous + Intratumoral | 15 | 58 |
 Intratumoral (IT) | 1 | 4 |
 Intraperitoneal (IP) +IV | 3 | 12 |
 IV + IT + IP | 1 | 4 |